# Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study

> **NCT00990665** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 178 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** CRT-D and LV lead (Quartet™ lead and Promote Q® device system)

## Key facts

- **NCT ID:** NCT00990665
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-09
- **Final completion:** 2012-07
- **Target enrollment:** 178 (ACTUAL)
- **Last updated:** 2019-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00990665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00990665, "Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00990665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*